SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-005606
Filing Date
2022-02-28
Accepted
2022-02-28 16:28:22
Documents
18
Period of Report
2022-02-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 89516
2 ex3-5.htm EX-3.5 11197
3 ex3-9.htm EX-3.9 5643
4 ex10-1.htm EX-10.1 206511
5 ex10-2.htm EX-10.2 75975
6 ex10-3.htm EX-10.3 82078
7 ex10-4.htm EX-10.4 79227
  Complete submission text file 0001493152-22-005606.txt   809308

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ogen-20220225.xsd EX-101.SCH 3036
9 XBRL LABEL FILE ogen-20220225_lab.xml EX-101.LAB 34476
10 XBRL PRESENTATION FILE ogen-20220225_pre.xml EX-101.PRE 22597
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3736
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 22690131
SIC: 2834 Pharmaceutical Preparations